Rights and permissions
About this article
Cite this article
Ranpirnase + rosiglitazone has potential for certain cancers. Inpharma Wkly. 1648, 9 (2008). https://doi.org/10.2165/00128413-200816480-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816480-00029